• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIV.

作者信息

Bressler Moshe Y, Delgado Axel R, Charlie Nelson

机构信息

Department of Dermatology, SUNY Downstate, Brooklyn, New York.

Department of Dermatology, Broward Health, Fort Lauderdale, Florida.

出版信息

JAAD Case Rep. 2023 Jan;31:118-120. doi: 10.1016/j.jdcr.2022.11.007. Epub 2022 Nov 12.

DOI:10.1016/j.jdcr.2022.11.007
PMID:36406337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9652155/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244a/9792697/fc57f489b093/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244a/9792697/1cee989f663c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244a/9792697/fc57f489b093/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244a/9792697/1cee989f663c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244a/9792697/fc57f489b093/gr2.jpg

相似文献

1
Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIV.一名感染HIV的患者在接种Moderna新冠疫苗后顽固性疣消退
JAAD Case Rep. 2023 Jan;31:118-120. doi: 10.1016/j.jdcr.2022.11.007. Epub 2022 Nov 12.
2
Recalcitrant verruca vulgaris regression following severe SARS-CoV-2 infection.严重的SARS-CoV-2感染后顽固性寻常疣消退
JAAD Case Rep. 2022 Oct;28:1-3. doi: 10.1016/j.jdcr.2022.07.034. Epub 2022 Aug 9.
3
Clearance of recalcitrant warts in a pediatric patient following administration of the nine-valent human papillomavirus vaccine.一名儿科患者在接种九价人乳头瘤病毒疫苗后顽固性疣的清除情况。
Pediatr Dermatol. 2020 Jul;37(4):748-749. doi: 10.1111/pde.14150. Epub 2020 Mar 15.
4
Vaccination against human papillomavirus is not associated with resolution of verruca vulgaris in immunocompetent 9- to 21-year olds.在免疫功能正常的9至21岁人群中，接种人乳头瘤病毒疫苗与寻常疣的消退无关。
J Am Acad Dermatol. 2022 Jul;87(1):250-252. doi: 10.1016/j.jaad.2021.08.016. Epub 2021 Aug 18.
5
Effect of Quadrivalent Human Papillomavirus Vaccination on Oral Squamous Cell Papillomas.四价人乳头瘤病毒疫苗对口腔鳞状细胞乳头瘤的影响。
JAMA Dermatol. 2015 Dec 1;151(12):1359-1363. doi: 10.1001/jamadermatol.2015.2805.
6
HPV Vaccination Status and Resolution of Warts in Pediatric Patients.儿科患者的人乳头瘤病毒疫苗接种状况与疣的消退情况
Indian J Dermatol. 2021 Nov-Dec;66(6):604-608. doi: 10.4103/ijd.ijd_30_21.
7
Treatment of recalcitrant verruca vulgaris with Candida antigen in patient with human immunodeficiency virus.用念珠菌抗原治疗人类免疫缺陷病毒患者的顽固性寻常疣。
J Drugs Dermatol. 2009 Mar;8(3):268-9.
8
Verruca vulgaris of the tongue.舌部寻常疣
J Maxillofac Oral Surg. 2013 Sep;12(3):329-32. doi: 10.1007/s12663-010-0097-5. Epub 2011 Mar 25.
9
HPV-57 Verruca Vulgaris Mimicking Epidermodysplasia Verruciformis.HPV-57 寻常疣样表现，类似疣状表皮发育不良。
Am J Dermatopathol. 2022 Aug 1;44(8):e94-e96. doi: 10.1097/DAD.0000000000002225. Epub 2022 May 30.
10
Resolution of diffuse facial verruca plana following nonavalent human papillomavirus immunization.九价人乳头瘤病毒免疫接种后扁平疣的消退
Pediatr Dermatol. 2020 Oct 8. doi: 10.1111/pde.14384.

本文引用的文献

1
Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases.化学修饰 mRNA 超越 COVID-19：针对慢性病的潜在预防和治疗应用。
Biomed Pharmacother. 2022 Jan;145:112385. doi: 10.1016/j.biopha.2021.112385. Epub 2021 Oct 28.
2
Regression of common viral warts after ChAdOx1-S COVID-19 vaccine.ChAdOx1-S新冠疫苗接种后寻常疣消退
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e162-e164. doi: 10.1111/jdv.17771. Epub 2021 Nov 13.
3
Repurposing Infectious Diseases Vaccines Against Cancer.
将传染病疫苗用于癌症防治。
Front Oncol. 2021 May 13;11:688755. doi: 10.3389/fonc.2021.688755. eCollection 2021.
4
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.报告的 Moderna 和辉瑞 COVID-19 疫苗接种后皮肤反应：基于登记的 414 例病例研究。
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
5
Plasmacytoid dendritic cell and type I interferons as possible explanation for clearance of longstanding warts during COVID-19 in a transplant patient, reply to Erkayman et al.浆细胞样树突状细胞和I型干扰素：一名移植患者在感染新冠病毒期间长期疣清除的可能解释，对埃尔凯曼等人的回应
Transpl Infect Dis. 2021 Aug;23(4):e13585. doi: 10.1111/tid.13585. Epub 2021 Feb 26.
6
Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient.COVID-19 期间移植受者长期治疗抵抗性疣的清除。
Transpl Infect Dis. 2021 Aug;23(4):e13572. doi: 10.1111/tid.13572. Epub 2021 Feb 16.
7
Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum.人乳头瘤病毒最新进展 - 第一部分：流行病学、发病机制及临床谱
An Bras Dermatol. 2021 Jan-Feb;96(1):1-16. doi: 10.1016/j.abd.2020.11.003. Epub 2020 Dec 10.
8
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System.乳头瘤病毒免疫逃逸策略针对受感染细胞和局部免疫系统。
Front Oncol. 2019 Aug 2;9:682. doi: 10.3389/fonc.2019.00682. eCollection 2019.
9
HPV vaccination in HIV infection.人类免疫缺陷病毒感染中的人乳头瘤病毒疫苗接种
Papillomavirus Res. 2019 Dec;8:100174. doi: 10.1016/j.pvr.2019.100174. Epub 2019 Jun 25.
10
Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas.人乳头瘤病毒疫苗与角质形成细胞癌发生的关联
JAMA Dermatol. 2017 Jun 1;153(6):571-574. doi: 10.1001/jamadermatol.2016.5703.